Ian W. Flinn, John M. Burke, Aung M. Tun, Ayed Ayed, Juliana M. L. Biondo, Mei Wu, Farah Hossain, Yong Mun, Rona Farighi, Avrita Singh, Jamal Misleh, Shachar Peles, L. Elizabeth Budde, Jose C. Villasboas, Jeff P. Sharman. "Fixed-duration subcutaneous (SC) mosunetuzumab (Mosun) in elderly/unfit patients with previously untreated diffuse large B-cell lymphoma (DLBCL): Interim analysis and patient-reported outcomes (PROs) from the phase 2 MorningSun study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7029